(December 14, 2017, 1:45 PM EST) -- BOSTON — Medtronic Inc. has agreed to pay $12 million to five states to resolve allegations that it engaged in deceptive marketing of the company’s Infuse bone graft, according to a consent judgment entered Dec. 13 in the Suffolk County, Mass., Superior Court (Commonwealth of Massachusetts v. Medtronic Sofamor Danek, Inc., et al., No. 17-4030D, Mass. Super., Suffolk Co.)....